BSD's MicroThermX Microwave Ablation System featured at CIRSE

BSD Medical Corporation (NASDAQ:BSDM) (the "Company" or "BSD") announced today that the MicroThermX Microwave Ablation System was featured at the Company's exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Valencia, Spain, October 2-6, 2010. CIRSE is Europe's largest and most comprehensive meeting for minimally invasive interventional radiology/oncology products. Over 5,000 clinicians from 70 different countries around the world attended CIRSE, reflecting the global impact of the rapidly expanding field of interventional radiology. The global market for ablation treatments is expected to reach $2.0 billion.

"The CIRSE meeting was effectively used to increase the profile of the Company's line of microwave ablation products and to further develop the Company's association with international key opinion leaders, many of whom frequented BSD's booth," stated Steven Smith, VP for Marketing and Business Development for BSD. "The tremendous success of the MicroThermX exhibit was evident by a constant stream of interested clinicians and medical distributors from around the world. BSD was pleased to have numerous medical distributors express excitement about the opportunity of selling the MicroThermX Microwave Ablation System. BSD met with distributors covering all of Latin and North America, Europe, the Mid East, South Africa, and Asia, including China, Korea and Japan."

The CIRSE scientific program highlighted the growing field of interventional oncology, including a series of presentations on the advantages and developments in the use of thermal ablation techniques in the treatment of solid tumors. One of the presentations reviewed the clinical advantages of microwave ablation, as compared to radiofrequency ablation, as a minimally invasive treatment for malignant solid tumors. The presenters reported that clinicians are embracing the advantages offered by minimally-invasive interventional oncology procedures like microwave ablation, including shorter patient recovery times, greater patient comfort and faster patient throughput.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Survey reveals many women unaware of minimally invasive uterine fibroid treatments